SCHEMBL212380

SCHEMBL212380

NC(=O)N1C=CNc2ccccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
SCN4A P35499 1/20 0.38
SCN5A Q14524 1/20 0.38
SCN9A Q15858 1/20 0.38
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BCHE P06276 1/20 0.37
ACHE P22303 1/20 0.37
HSD17B3 P37058 1/20 0.33
KDM4E B2RXH2 1/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPT P10636 1/20 0.31
PABPC1 P11940 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31
P2RX4 Q99571 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7433336 0.84 GAA (0.38) LMNAGAASMN1; SMN2BCHEHSD17B3
SCHEMBL38658293 0.74 BCHE (0.46) MAPK1SCN5ASCN9AGAASMN1; SMN2
SCHEMBL16342946 0.74 P2RX4 (0.46) LMNATSHRSCN9AGAASMN1; SMN2
SCHEMBL8333405 0.72 GAA (0.31) GAASMN1; SMN2
SCHEMBL7345762 0.71 GAA (0.34) GAASMN1; SMN2
SCHEMBL1598178 0.71 GAA (0.31) GAASMN1; SMN2
SCHEMBL9398001 0.69 APEX1 (0.36) GAASMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL4372136 0.67 BRPF1 (0.36) GAASMN1; SMN2KMT2A
SCHEMBL3120276 0.67 GAA (0.31) GAASMN1; SMN2
SCHEMBL8338720 0.67 GAA (0.32) GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-8088793-B2 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. (US) 2012-01-03 US disclosed
EP-2268285-A1 THERAPEUTIC COMPOUNDS Merck Sharp & Dohme Corp. (US) 2011-01-05 EP disclosed
WO-2009108507-A1 THERAPEUTIC COMPOUNDS MERCK & CO., INC. (US) 2009-09-03 WO disclosed
WO-2006068928-A1 PYRROLO[1,2-A]QUINOXALIN-5-(4H)-YL)SULFONYLS AND CARBONYLS AND THEIR USE AS ESTROGENIC AGENTS WYETH (US) 2006-06-29 WO disclosed
EP-1507778-A4 ANTI-TUMOUR POLYCYCLIC CARBOXAMIDES UNIV TROBE (AU) 2006-05-31 EP disclosed
EP-1507778-A1 ANTI-TUMOUR POLYCYCLIC CARBOXAMIDES LA TROBE UNIVERSITY (AU) 2005-02-23 EP disclosed
WO-2003097642-A1 ANTI-TUMOUR POLYCYCLIC CARBOXAMIDES LA TROBE UNIVERSITY (AU) 2003-11-27 WO disclosed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO disclosed
WO-1998045272-A1 TOPOISOMERASE INHIBITORS LATROBE UNIVERSITY (AU) 1998-10-15 WO disclosed